FOI release

FOI regarding chemical BHT still contained in ingested vitamin D products

Case reference FOI2025/00307

Received 27 March 2025

Published 30 May 2025

Request

Yes please could I have the risk management plan for this and the list of adverse affects. If a cost is incurred I will be happy to pay (depending on how much)

Response

see attached

Documents

• FOI2025.00307 redacted for publication.pdf (100.3 KB)
• FOI2025_00307 Fultium D3 Product Analysis Print.pdf (100.7 KB)
• risk-management-system Fultium-D3 (redacted).pdf (12.2 MB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.